GOG-0270

Closed to Accrual

Return to Protocol Table

GROningen INternational Study on Sentinel Nodes in Vulvar Cancer (GROINSS-V) II: An Observational Study

Principal Investigator

Brian M. Slomovitz

Status

Closed to Accrual

Open to Accrual

January 3, 2012

Closed to Accrual

October 7, 2016


Disease Site

Gynecologic [GY] Other

Phase

Other

Developmental Therapeutics

No

Primary Objective

Patient must have squamous cell carcinoma with a depth invasion > 1mm.
Patients must have T1 or T2 tumors (FIGO staging) < 4cm, not encroaching in urethra, vagina or anus with clinically negative inguinofemoral lymph nodes.
Localization and size of the tumor are such that peri-lesional injection of the tracers at three or four sites is possible.
Preoperative imaging does not show enlarged (< 1.5 cm) suspicious nodes.

Patient Population

Patient must have squamous cell carcinoma with a depth invasion > 1mm.
Patients must have T1 or T2 tumors (FIGO staging) < 4cm, not encroaching in urethra, vagina or anus with clinically negative inguinofemoral lymph nodes.
Localization and size of the tumor are such that peri-lesional injection of the tracers at three or four sites is possible.
Preoperative imaging does not show enlarged (< 1.5 cm) suspicious nodes.

Target Accrual

140

Patient Study Webpage

There is no available patient study webpage available for this trial at this time.